Burren Capital Advisors’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Burren Capital Advisors’s Portfolio ITCI Stock Details ITCI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,074	Closed	-$2.65M	–	22
2025 Q1	$2.65M	Buy	+20,074	New	+$2.5M	9.47%	5

Other funds holding ITCI

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

KIM

Kestra Investment Management Austin, Texas $5.16B AUM 18.64% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Burren Capital Advisors's ITCI Position: Q2 2025 in Review

Burren Capital Advisors sold out of Intra-Cellular Therapies Inc. (ITCI) in Q2 2025, closing a stake of 20,074 shares — an estimated $2.65M sold.

Burren Capital Advisors first reported a position in ITCI in Q1 2025 and held it in 1 quarter. The position peaked at $2.65M in Q1 2025. 4 funds tracked by Wall St. Rank hold ITCI as of Q2 2025.

Burren Capital Advisors reported no remaining Intra-Cellular Therapies Inc. position as of Q2 2025 after selling out during the quarter.
Burren Capital Advisors sold 20,074 Intra-Cellular Therapies Inc. shares in Q2 2025, an estimated $2.65M.
Burren Capital Advisors first reported a position in Intra-Cellular Therapies Inc. in Q1 2025 and held it in 1 quarter.
Burren Capital Advisors's Intra-Cellular Therapies Inc. position peaked at $2.65M in Q1 2025.
4 funds tracked by Wall St. Rank held Intra-Cellular Therapies Inc. as of Q2 2025.

Based on Burren Capital Advisors's 13F filing for Q2 2025, filed 7 Aug 2025.